A hypodermic needle is a cylindrical hollow needle that is commonly used in medical settings for a variety of purposes, including medicine vaccination, delivery, and blood specimen collection.

New York, June 30, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hypodermic Needles Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End Users, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.com/p06289259/?utm_source=GNW These needles have two types of mechanisms viz. safety and non-safety needles. They are used to give and inject medications into the body, as well as to remove bodily fluids for analysis and research. The rise of the hypodermic needles industry is fueled by the rising frequency of chronic infectious disorders like Hepatitis B and C. According to the World Health Organization, in 2019, 296 million individuals were estimated to have chronic hepatitis B infection, with 1.5 million new cases per year. Hepatitis B caused an estimated 820,000 fatalities, and hundreds of thousands of healthcare professionals were exposed to contaminated needle sticks or sharp injuries, putting them at risk for work-related illnesses such as hepatitis B, hepatitis C, and HIV. Furthermore, hypodermic needles are utilized to administer vaccines to patients during vaccination. According to the Organization, a total of 11,324,805,837 COVID-19 vaccine doses had been provided worldwide as of April 17, 2022, which is anticipated to boost demand for hypodermic needles. The market is estimated to rise due to an increase in the incidence of chronic and lifestyle illnesses, particularly an increase in the prevalence of diabetes worldwide, technological improvements in the hypodermic needles industry, and increased demand for improved hypodermic needles solutions. In addition, the increase in the demand for hypodermic needles, as well as rising disposable incomes and growth prospects in various countries, are likely to create several prospects for the hypodermic needles market. Furthermore, the increasing prominence of key manufacturing businesses that produce and distribute hypodermic needles, as well as an increase in healthcare spending, are driving the growth of the hypodermic needles market COVID-19 Impact The COVID-19 pandemic caused severe harm to various businesses all over the world. The outbreak of the pandemic significantly disrupted various economies all over the world. In the initial period of the COVID-19 spread, several markets witnessed a shortage of labor and workforce. In addition, to regulate the rapid spread of the COVID-19 infection, governments across the world were compelled to impose a lockdown in their countries. The lockdown scenario led the worldwide economy to the closure of several companies and manufacturing units of numerous goods and services. Moreover, worldwide governments also enforced stringent travel restrictions in their countries, due to which, there was a major disruption in the global supply chain. As a result, lockdown and supply chain disruption caused generated a significant demand-supply gap in the market. Market Growth Factors Reduced pain along with lesser risk of contamination Because of the reduced risk of infection or contamination, hypodermic needles are becoming very popular all over the world. Since every hypodermic needle is entirely smooth, airborne pathogens have a harder time settling on it. Another rationale for the low risk of contamination is the needle’s small diameter, which creates a very small hole when penetrating a vein. This function of the hypodermic needle significantly aids in the reduction of pain for the patient. Moreover, it can also aid in the prevention of infection because fewer germs or microbes would be able to penetrate the body through the tiny perforation. Rising number of diabetic patients all over the world With rapid urbanization and modernization, the lifestyle of people all over the world is rapidly evolving. One of the major changes in the lifestyle of people is the adoption of a sedentary lifestyle due to extended working hours along with the hectic lifestyle of people. Due to this transition, the number of people with various chronic diseases is rising. In the modern era, the food consumption of people has been significantly altered by junk food and other unhealthy edibles. Diabetic is a major risk factor that is associated with this lifestyle of people. Due to the increased sedentary lifestyle among people, the rate of obesity all over the world is increasing. Obesity is one of the most prevalent factors that cause diabetes in people. Market Restraining Factors Increasing cases of Trypanophobia Hypodermic needles are extremely helpful in the entire healthcare setting as it considerably streamlines the process of injecting any medicine into the body of a patient through their vein. However, there is a major impeding factor that is hindering healthcare professionals from leveraging hypodermic needles. Trypanophobia is an irrational and extreme fear of medical treatments involving needles. It’s linked to phobias of needles, pins, and other sharp items. Patients that are suffering from this phobia are extremely afraid of any kind of needle that is being used in both medical and non-medical settings. People with trypanophobia experience severe anxiety when they see or hear about a needle operation. Product Outlook Based on Product, the market is segmented into Safety and Non-safety. In 2021, the safety hypodermic needles segment acquired the largest revenue share of the hypodermic needles market. The increasing growth of the segment is owing to the developments in R&D activities across the healthcare sector as well as an increase in the occurrence of needlestick injury. Because of the ease and safety that these goods provide, safety hypodermic needles are broadly adopted among customers all over the world. Luer lock, single-handed technique along with other safety features is included in safety hypodermic needles. Application Outlook Based on Application, the market is segmented into Drug Delivery, Vaccination and Blood Specimen Collection. In 2021, the vaccination segment recorded a significant revenue share of the hypodermic needles market. For immunization processes, hypodermic needles of various sizes can be used. The gauge refers to the needle tubing’s outer diameter. The smaller the needle’s diameter, the higher the gauge number. Many vaccines are advised for intramuscular injection, while others can also be given subcutaneously or intradermally. Choosing the right needle length and gauge can help ensure that vaccination is delivered to the right place and creates the best immune response while causing the least amount of harm. End Users Outlook Based on End Users, the market is segmented into Hospital, Diabetic Patients, Family Practitioners, Psychiatry and Others. In 2021, the hospitals segment witnessed the largest revenue share of the hypodermic needles market. The increasing growth of the segment is attributed to the rising demand for minimally invasive surgeries Hypodermic needles are commonly used in hospitals for a variety of purposes, including immunization, medicine delivery, blood sample collection, and more. In addition, hospitals in wealthy countries have made the use of hypodermic needles mandatory. To avoid the spread of blood-borne infections like hepatitis, HIV, and viral hemorrhagic fevers, the World Health Organization (WHO) has advised all healthcare practitioners to switch to safer needles. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, Asia-Pacific accounted for the largest revenue share of the hypodermic needles market. The rapidly increasing growth of the regional market is attributed to an increase in the prevalence of chronic diseases, the presence of a large population base (with India and China being two of the most populated countries), the presence of unmet medical needs, an increase in people’s disposable incomes, and a rise in awareness about the utilization of hypodermic needles in the region. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, McKesson Corporation, Retractable Technologies, Inc., Connecticut Hypodermics, Inc., Exelint International, Co., and i-Tech Medics Private Limited. Strategies deployed in Hypodermic Needles Market May-2022: BD partnered with Mitsubishi Gas Chemical Company, a manufacturer of chemical products. With this partnership, the companies aimed to develop new technology for pre-fillable syringes. Moreover, BD would leverage Oxycapt technology of MGC and apply them to advanced pre-fillable syringes. Nov-2021: BD rolled out BD UltraSafe Plus, a 2.25 mL Passive Needle Guard. Following the product launch, the company aimed to offer a system to pharmaceutical companies, which, when combined with Glass Prefillable Syringes, activates the subcutaneous distribution of biologic solutions of distinct fill volumes of nearly 2 mL as well as viscosities up to 30 cP. Jul-2021: Terumo partnered with BioCentriq, a contract manufacturing, and development organization. This partnership aimed to expedite the adoption of automated manufacturing in order to develop new cell and gene therapies for patients at a rapid pace and lesser cost. Apr-2021: Nipro PharmaPackaging introduced CURACASE, a hypodermic needle in hard-plastic unit packaging. With this launch, the company aimed to strengthen its capability of manufacturing and distributing injection systems across the pharmaceutical industry. Jul-2020: BD entered into a partnership with Biomedical Advanced Research and Development Authority, a unit of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Following this partnership, the entities would develop novel production lines for injection devices in order to deliver priority access to the United States government to a massive volume of needles and syringes in order to support present as well as future pandemic vaccination efforts. Sep-2019: Terumo unveiled fentanyl injection, a prescription-only analgesic. Through this launch, the company aimed to offer an analgesic to Japanese healthcare practitioners widely employed for the post or during-operation pain management. Jul-2018: Terumo released PLAJEX, a pre-fillable syringe in Europe. The unique manufacturing and design of PLAJEX aimed to reduce risks like oxidation and aggregation of biopharmaceuticals. Scope of the Study Market Segments covered in the Report: By Product • Safety and • Non-safety By Application • Drug Delivery • Vaccination • Blood Specimen Collection By End User • Hospital • Diabetic Patients • Family Practitioners • Psychiatry • Others By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • Becton, Dickinson and Company • Terumo Corporation • Nipro Corporation • Cardinal Health, Inc. • B. Braun Melsungen AG • McKesson Corporation • Retractable Technologies, Inc. • Connecticut Hypodermics, Inc. • Exelint International, Co. • Hi-Tech Medics Private Limited Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06289259/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.

Is Johnson & Johnson stock a buy after the company unveiled positive results in cancer treatment this month? Is JNJ stock a buy?

The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.

The Los Angeles-based company is far different from Athenex, developing different kinds of cancer drugs and building its own business model around those plans, but it also has some notable similarities.

Gut health is important for so many reasons! First of all, when the gut is unhealthy it can lead to a variety of digestive symptoms such as heartburn, abdominal pain, bloating, excess gas, constipation, and diarrhea, just to name a few. These symptoms can be very disruptive to daily life and can get in the way of work, school, relationships, and even enjoying a normal meal. Another reason it's important to have a healthy gut is that the gut is connected to so many other body systems. For this re

A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

A group of researchers has some counterintuitive advice: Saving your poop now could save your life someday.

Early studies suggested that certain blood types may leave you more at risk of Covid. Newer science confirms that Type O might help you resist infection.

(Bloomberg) -- Alphabet Inc.’s Google said it will automatically delete records of user visits to sensitive locations, including abortion clinics, responding to growing concerns that the data could be used to prosecute those seeking reproductive care and other personal services.Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysCrypto Meltdown Claims Rolex and Patek Philippe as VictimsHow Europe Became the Epicenter for This Summer’s Travel ChaosThe Wheels Have

(Bloomberg) -- The US Supreme Court turned away a challenge to New York’s Covid-19 vaccine requirement for health-care workers, rejecting an appeal from 16 people who objected to the shot on religious grounds.Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesStock Doomsayers Vindicated in Historic First Half: Markets WrapCrypto Meltdown Claims Rolex and Patek Philippe as VictimsUkraine Latest: Kyiv Lauds Isle Retake; P

Kristin Cavallari shared a new photo of herself in a bikini, showing off the fitness progress she has made since dedicating herself to a healthier lifestyle.

The U.S. Food and Drug Administration on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants of the coronavirus. If authorized, the changes would mark the first major retooling of COVID vaccines, but also could slow their rollout as the FDA has recommended a design somewhat different from what the companies had already tested and started producing. The FDA will not require new studies testing the BA.4/BA.5 shots in humans to be completed for authorization, a top agency official told Reuters, similar to how annual changes to flu vaccines are handled.

The current strain on the foster care system nationwide is evident and creates a lack of stability for children in the system.

There are “super-immunity” particles in llama blood, according to the research.

Attorney General Merrick Garland will undergo general anesthesia next Thursday for a routine surgical procedure to treat a prostate condition, the Justice Department announced. The department said Garland was diagnosed with benign prostatic hyperplasia, an enlargement of the prostate gland that is not cancerous and affects millions of older men, according to the National Institutes…

The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.

'I make no judgements about women who have abortions. I don’t know their circumstances, religious views, or knowledge of biology'

"As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.

(Bloomberg) -- House Democrats are attempting a likely doomed effort to expand federal funding for abortions under Medicaid as progressives grasp for ways to respond after the Supreme Court last week ended the nationwide right to an abortion in place since 1973.Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysCrypto Meltdown Claims Rolex and Patek Philippe as VictimsThe Wheels Have Come Off Electric VehiclesHow Europe Became the Epicenter for This Summer’s Tr

Nearly two dozen people have been sickened with listeria, and one has died, according to the Centers for Disease Control and Prevention, which said the source of the outbreak has not been identified.